Figure 3
Molecular phenotype of GVHD progression. Bone marrow and splenocytes from C57BL/6J females were used to induce GVHD in five allogenic 129P3/J males (C57BL6/J → 129P3/J). Five syngeneic transplant recipients (C57BL6/J → C57BL6/J) were used as controls. cDNAs were prepared from samples collected on days 7 and 9 after the transplant and were subjected to IMQ/GPR analysis. The fold changes of genes that received a GPR score ≥0.4 and were significant after normalization to 18S rRNA are shown.
